CLADE THERAPEUTICS

clade-therapeutics-logo

Clade Therapeutics is a biopharmaceutical company focused on discovering and delivering scalable, off-the-shelf, next-generation stem-cell-based medicines. The company was incorporated in 2020 and has been operating in Cambridge, Massachusetts, United States.

#SimilarOrganizations #People #Financial #Event #Website #More

CLADE THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
2020-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.cladetx.com

Total Employee:
11+

Status:
Active

Contact:
415-886-7710

Email Addresses:
[email protected]

Total Funding:
87 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

obsidian-therapeutics-logo

Obsidian Therapeutics

Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.

stealth-therapeutics-logo

Stealth Therapeutics

Stealth Therapeutics is a developer of an implantable port used to improve the lives of patients.

Current Employees Featured

derek-hei_image

Derek Hei
Derek Hei CTO @ Clade Therapeutics
CTO
2022-03-10

leandro-vetcher_image

Leandro Vetcher
Leandro Vetcher Chief Operating Officer, Co-Founder @ Clade Therapeutics
Chief Operating Officer, Co-Founder

chad-cowan_image

Chad Cowan
Chad Cowan Co-Founder&CEO @ Clade Therapeutics
Co-Founder&CEO

jim-glasheen_image

Jim Glasheen
Jim Glasheen President / Co-founder @ Clade Therapeutics
President / Co-founder
2021-01-01

Founder


chad-cowan_image

Chad Cowan

jim-glasheen_image

Jim Glasheen

leandro-vetcher_image

Leandro Vetcher

Investors List

emerson-collective_image

Emerson Collective

Emerson Collective investment in Series A - Clade Therapeutics

syncona-partners-llp_image

Syncona Partners LLP

Syncona Partners LLP investment in Series A - Clade Therapeutics

lifesci-venture-partners_image

LifeSci Venture Partners

LifeSci Venture Partners investment in Series A - Clade Therapeutics

bristol-myers-squibb_image

Bristol Myers Squibb

Bristol Myers Squibb investment in Series A - Clade Therapeutics

Official Site Inspections

http://www.cladetx.com Semrush global rank: 4 M Semrush visits lastest month: 3.11 K

  • Host name: angiecocuzza.tempurl.host
  • IP address: 45.77.216.198
  • Location: Piscataway United States
  • Latitude: 40.5511
  • Longitude: -74.4606
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 08854

Loading ...

More informations about "Clade Therapeutics"

Clade Therapeutics - Crunchbase Company Profile

Contact Email [email protected] Phone Number 415-886-7710 Clade Therapeutics is a biopharmaceutical company focused on discovering and …See details»

Clade Therapeutics, Inc. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Clade …See details»

Clade Therapeutics, Inc. - Drug pipelines, Patents, Clinical

Cladetx.com. Startups | Subsidiary Company | 2020 | Massachusetts, United States | 100-250 | …See details»

Clade Therapeutics Company Profile 2024: Valuation, Investors ...

Clade Therapeutics General Information Description. Developer of cell therapies designed to …See details»

Clade Therapeutics - Overview, News & Similar companies

Oct 2, 2023 Clade Therapeutics Raises $87 Million Series A Financing to Realize the …See details»

Clade Therapeutics - LinkedIn

Clade Therapeutics | 5,911 followers on LinkedIn. Clade Therapeutics is a well-funded cell …See details»

Clade Therapeutics - VentureRadar

"Our platform technology immune “cloaks” human pluripotent stem cells and their adult …See details»

Clade Therapeutics Raises $87 Million Series A Financing to …

Nov 3, 2021 Clade’s iPSC immune cloaking and differentiation platform technology to address …See details»

Clade Therapeutics Announces the Acquisition of Gadeta B.V.

Feb 10, 2023 Expands Clade’s pipeline and broadens its platform with: - proprietary …See details»

Clade Therapeutics - VentureRadar

Website: https://cladetx.com/ Develops off-the-shelf stem cell-based medicines using platform …See details»

Series A - Clade Therapeutics - 2021-11-03 - Crunchbase

Nov 3, 2021 Organization Name . Clade Therapeutics . Announced Date Nov 3, 2021; …See details»

Clade Therapeutics Announces the Acquisition of Gadeta B.V.

Oct 2, 2023 Expands Clade’s pipeline and broadens its platform with:- proprietary …See details»

Clade Therapeutics acquires Gadeta - 2023-10-02 - Crunchbase

Oct 2, 2023 Acquiring Organization: Clade Therapeutics Clade Therapeutics discovers and …See details»

Clade Therapeutics Announces The Acquisition Of Gadeta BV

Oct 2, 2023 <p>Clade Therapeutics (&ldquo;Clade&rdquo;), a biopharmaceutical company …See details»

Clade Therapeutics on LinkedIn: Clade Therapeutics Announces …

Clade Therapeutics is excited to welcome the Gadeta team into the Clade family. This …See details»

Clade Therapeutics Announces the Acquisition of Gadeta B.V.

Feb 10, 2023 Expands Clade’s pipeline and broadens its platform with:- proprietary …See details»

Clade Therapeutics, Inc. | Tech Launch Arizona

Clade's platform technology immune “cloaks” human pluripotent stem cells and their adult …See details»

Clade Therapeutics Raises $87 Million Series A Financing to

CAMBRIDGE, Mass., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Clade Therapeutics, a …See details»

Clade Therapeutics | VentureRadar

Similar Companies: RHEACELL Germany n/a RHEACELL is a biopharmaceutical company …See details»

Clade Therapeutics Announces the Appointment of Derek Hei,

Mar 10, 2022 Dr. Hei has spent over two decades leading manufacturing teams at …See details»

linkstock.net © 2022. All rights reserved